Barry Eisenstein

Barry I. Eisenstein, M.D. has served as our Senior Vice President, Scientific Affairs since July 2004. From January 2003 until July 2004 he served as our Senior Vice President, Research and Development, where he helped lead the FDA approval team for CUBICIN